Clinical Trial Update: Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bevacizumab with carmustine in relapsed or progressive high-grade glioma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Carmustine (carmustine)

Snippet

Sponsor: University of California, Davis | Conditions: Glioma | Phase 2 | Status: COMPLETED | Results posted: 2020-05-12